Table 2.
Diagnostic criteria of the receiver operating characteristic (ROC) curve for the tested parameters.
| Marker | Unit | AUC | p (AUC = 0.50) | Cut Off Value | Sensitivity | Specificity | OR | p |
|---|---|---|---|---|---|---|---|---|
| 25-OH vitamin D PS | mg/mL | 0.59 | NS | <26.18 | 0.85 | 0.40 | 1.62 | NS |
| 25-OH vitamin D AF | mg/mL | 0.66 | NS | <31.21 | 0.85 | 0.50 | 3.27 | NS |
| Asprosin PS | ng/mL | 0.97 | <0.0001 | >12.70 | 1.00 | 0.85 | 8.20 | p < 0.05 |
| Asprosin AF | ng/mL | 0.83 | <0.001 | >12.91 | 0.95 | 0.65 | 22.78 | p < 0.05 |
| AGE PS | ng/mL | 0.85 | <0.001 | <11.00 | 0.81 | 0.80 | 1.00 | NS |
| AGE AF | ng/mL | 0.96 | <0.0001 | <4.184 | 0.95 | 0.90 | 2.11 | p < 0.05 |
| IMA PS | µg/mL | 0.84 | <0.001 | <4.798 | 0.67 | 1.00 | 1.05 | NS |
| IMA AF | µg/mL | 0.54 | NS | <1.798 | 0.38 | 0.76 | 0.18 | p < 0.05 |
| A1AT PS | mg/L | 0.53 | NS | <2.341 | 0.81 | 0.33 | 5.75 | p < 0.05 |
| A1AT AF | mg/L | 0.87 | <0.0001 | <0.3180 | 0.76 | 0.86 | 0.71 | NS |
| DNA/RNA OSDP PS | pg/mL | 0.51 | NS | <40.30 | 0.80 | 0.40 | 3.27 | NS |
| DNA/RNA OSDP AF | pg/mL | 0.73 | <0.05 | >31.76 | 0.84 | 0.58 | 3.78 | NS |
A1AT, alfa-1-antitrypsin; AF, amniotic fluid; AGE, advanced glycation end products; AUC, area under the received operative characteristic (ROC) curve; IMA, ischemia-modified albumin; NS, not significant; OR, odds ratio; OSDP, oxidative stress damage product; PS, plasma.